30 Day Trial

About ORTHOWORLD

Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.

ORTHOFLASH Subscribe

03/28/2017
  • 12:00 p.m. Medeon Biodesign closed a Series A investment in Panther Orthopedics, a start-up developing devices for dynamic fracture fixation in the extremities.
  • Integra LifeSciences commenced full commercial launch of the Cadence® Total Ankle in Canada, the U.S. and select EU regions.
  • Burst Biologics received IRB approval for a U.S. prospective clinical study of BioBurst cellular allograft in spinal fusion.
Read More

Articles of Interest All Articles

More Highlights from the Floor: AAOS 2017

More of what's new at AAOS, including value-focused initiatives, robotics and personalized solutions.